Ofelia Romero

Statistics

Publications

Citations

218

H-Index

Active since

2008

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Ofelia Romero is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, medicine, and cancer pharmacology.

Publications per year

2008–2023

Publications

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

Monica Mita, Matthew A. Spear, Lorrin Yee et al. · Clinical Cancer Research · 2010 · 107 citations

Medicine, Oncology, Pharmacology +16

Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies

Monica Mita, Kevin R. Kelly, Alain C. Mita et al. · Clinical Cancer Research · 2011 · 71 citations

Medicine, Oncology, Pharmacology +14

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies

Monica Mita, Alain C. Mita, John Sarantopoulos et al. · Cancer Chemotherapy and Pharmacology · 2008 · 29 citations

Medicine, Oncology, Pharmacology +11

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Devalingam Mahalingam, Salih Hanni, Anthony V. Serritella et al. · Oncotarget · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13

1–4 of 4